Tenax Therapeutics, Inc. · NASDAQ:TENX
Morgan Stanley's stake in Tenax Therapeutics, Inc. fell to 3.50% (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 8, 2026
Morgan Stanley's stake in Tenax Therapeutics, Inc. fell to 3.50%, 596,564 shares, as a passive investor on Mar 31, 2026. Filed Apr 8, 2026 (Schedule 13G/A).
- Stake
- 3.50%
- Shares
- 596,564
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 3.50% | 596,564 |
| Morgan Stanley Capital Services LLC | 3.40% | 583,297 |
Source
Related
- Tenax Therapeutics, Inc.
- Morgan Stanley
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G · Morgan Stanley · Feb 12, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026